Literature DB >> 7972619

A test of generalizability of cardiovascular reactivity using a controlled ambulatory procedure.

W Gerin1, M Rosofsky, C Pieper, T G Pickering.   

Abstract

This study tested the hypothesis that reports of poor generalizability of cardiovascular reactivity measured in the laboratory to changes observed during everyday life are due to a lack of standardization of activities and position (sitting, standing) in the latter situation. Thirty-seven subjects engaged in reactivity testing, and then in a 4-hour series of standardized activities outside the laboratory (controlled ambulatory phase), accompanied by the experimenter, on each of 2 days. The controlled ambulatory activities included alphabetizing, an editing task, a brisk walk, solving word puzzles, and eating lunch. Two measures of field variability were examined: the standard deviation and the root mean square of successive differences, of all ambulatory measurements. Associations between laboratory changes scores and measures of field variability were poor (highest r = .23). We conclude that evidence for generalizability of reactivity change scores remains poor, and cannot be solely attributed to the uncontrolled nature of activities in the field.

Mesh:

Year:  1994        PMID: 7972619     DOI: 10.1097/00006842-199407000-00012

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  3 in total

1.  Idiodynamic profiles of cardiovascular activity: a P-technique approach.

Authors:  Bruce H Friedman; Aimee K Santucci
Journal:  Integr Physiol Behav Sci       Date:  2003 Oct-Dec

2.  Genetic influence on blood pressure measured in the office, under laboratory stress and during real life.

Authors:  Xiaoling Wang; Xiuhua Ding; Shaoyong Su; Gregory Harshfield; Frank Treiber; Harold Snieder
Journal:  Hypertens Res       Date:  2010-11-11       Impact factor: 3.872

3.  What is the true blood pressure? Smirk revisited.

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-07       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.